Tibet Rhodiola Pharmaceutical Holding Co

SHG:600211 China Drug Manufacturers - Specialty & Generic
Market Cap
$1.92 Billion
CN¥14.12 Billion CNY
Market Cap Rank
#8426 Global
#1597 in China
Share Price
CN¥43.81
Change (1 day)
+4.16%
52-Week Range
CN¥35.37 - CN¥56.43
All Time High
CN¥165.99
Categories
Companies in China Drug Manufacturers - Specialty & Generic
About

Tibet Rhodiola Pharmaceutical Holding Co. manufactures pharmaceuticals in China and internationally. The company offers biological products, Tibetan medicine, Chinese medicine, and chemical medicine products. It also provides capsules, biological preparations, granules, and film-coating agents for cardiovascular, cerebrovascular, hepatobiliary, sprains and contusions, rheumatism, rheumatoid arthr… Read more

Tibet Rhodiola Pharmaceutical Holding Co - Asset Resilience Ratio

Latest as of September 2025: 21.16%

Tibet Rhodiola Pharmaceutical Holding Co (600211) has an Asset Resilience Ratio of 21.16% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
CN¥1.23 Billion
Cash + Short-term Investments
Total Assets
CN¥5.82 Billion
All company assets
Resilience Assessment
Good
Financial Resilience Level

Asset Resilience Ratio Trend (2002–2024)

This chart shows how Tibet Rhodiola Pharmaceutical Holding Co's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Tibet Rhodiola Pharmaceutical Holding Co's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥1.23 Billion 21.16%
Total Liquid Assets CN¥1.23 Billion 21.16%

Asset Resilience Insights

  • Good Liquidity Position: Tibet Rhodiola Pharmaceutical Holding Co maintains a healthy 21.16% of assets in liquid form.
  • This level provides good financial flexibility while maintaining productive asset deployment.
  • The company has significant short-term investments, indicating active treasury management.

Tibet Rhodiola Pharmaceutical Holding Co Industry Peers by Asset Resilience Ratio

Compare Tibet Rhodiola Pharmaceutical Holding Co's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF 		Drug Manufacturers - Specialty & Generic -0.02%
Kamada
NASDAQ:KMDA 		Drug Manufacturers - Specialty & Generic 21.63%
Dongwha Pharm.Co.Ltd
KO:000020 		Drug Manufacturers - Specialty & Generic 1.92%
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078 		Drug Manufacturers - Specialty & Generic 0.46%
Yuhan Corp.
KO:000100 		Drug Manufacturers - Specialty & Generic 0.99%
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153 		Drug Manufacturers - Specialty & Generic 1.81%
Kotra Industries Bhd
KLSE:0002 		Drug Manufacturers - Specialty & Generic 9.82%
Yuyu Pharma Inc
KO:000227 		Drug Manufacturers - Specialty & Generic 1.74%

Annual Asset Resilience Ratio for Tibet Rhodiola Pharmaceutical Holding Co (2002–2024)

The table below shows the annual Asset Resilience Ratio data for Tibet Rhodiola Pharmaceutical Holding Co.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 20.57% CN¥976.62 Million CN¥4.75 Billion +9.34pp
2023-12-31 11.23% CN¥515.34 Million CN¥4.59 Billion -8.10pp
2022-12-31 19.33% CN¥792.49 Million CN¥4.10 Billion +5.19pp
2021-12-31 14.14% CN¥537.87 Million CN¥3.80 Billion +13.64pp
2020-12-31 0.51% CN¥14.96 Million CN¥2.94 Billion -2.74pp
2019-12-31 3.25% CN¥90.00 Million CN¥2.77 Billion +0.41pp
2016-12-31 2.84% CN¥65.00 Million CN¥2.29 Billion +2.80pp
2010-12-31 0.04% CN¥308.80K CN¥735.47 Million -0.05pp
2009-12-31 0.10% CN¥709.60K CN¥743.70 Million +0.08pp
2008-12-31 0.01% CN¥112.40K CN¥829.66 Million -0.03pp
2007-12-31 0.04% CN¥339.80K CN¥831.96 Million +0.01pp
2006-12-31 0.03% CN¥252.00K CN¥866.90 Million +0.02pp
2005-12-31 0.01% CN¥114.60K CN¥820.62 Million -0.46pp
2004-12-31 0.48% CN¥3.69 Million CN¥777.25 Million -0.03pp
2003-12-31 0.51% CN¥3.81 Million CN¥754.36 Million +0.05pp
2002-12-31 0.46% CN¥3.37 Million CN¥733.08 Million --
pp = percentage points